#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Alpha-1 antitrypsin deficiency Ocular myasthenia Primary biliary cholangitis Homocystinuria Liposarcoma Demyelination Haemophagocytic lymphohistiocytosis Autoimmune demyelinating disease Pulmonary sarcoidosis Neuroendocrine tumour Transitional cell carcinoma Gestational trophoblastic tumour Acquired haemophilia Cholangiocarcinoma Meningitis meningococcal More trials…
Learn about Rare Diseases

Gaucher’s disease type III – Trials in Disease Malignant fibrous histiocytoma Alternating hemiplegia of childhood – Treatment Retinoblastoma – Basic Information Familial haemophagocytic lymphohistiocytosis – Basic Information Skin angiosarcoma – Life with Disease Myelodysplastic syndrome – Diagnostics Adrenocortical carcinoma – Life with Disease Gaucher’s disease type III – Basic Information Toxic epidermal necrolysis – Basic Information More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Zanamivir Tilsotolimod Sodium S-241656 Odevixibat Everolimus Gsk6097608 Sodium Nitrite GSKVX000000040033 ELTANEXOR Clobetasol Propionate Ro7269162 Paracetamol Polydextrose Dabigatran Etexilate Imiquimod Ag-946 Pyrazinamide Apl-101 Aciclovir Sodium Hydrogen Carbonate More therapies…

Learn about Your Condition

Neuropathic arthropathy Giardiasis Gastrointestinal disorder Marfan's syndrome Rett syndrome Neoplasm malignant Metastases to meninges Lipid metabolism disorder Malabsorption COVID-19 Factor VIII deficiency Piriformis syndrome Alveolar proteinosis Endometrial cancer stage I Angiopathy More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Penile squamous cell carcinoma

Study of enfortumab vedotin and avelumab for patients with advanced or metastatic penile cancer that has spread or cannot be removed by surgery

Recruiting

2 1 1 1
Investigated Diseases:
- Penile squamous cell carcinoma
Investigated Drugs:
- Avelumab
- Enfortumab Vedotin
Study on Avelumab for Patients with Advanced or Metastatic Squamous Cell Penile Cancer After Initial Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Penile squamous cell carcinoma
Investigated Drugs:
- Avelumab
Study of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Vorinostat
- Pembrolizumab

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Penile squamous cell carcinoma

Study of enfortumab vedotin and avelumab for patients with advanced or metastatic penile cancer that has spread or cannot be removed by surgery

Study on Avelumab for Patients with Advanced or Metastatic Squamous Cell Penile Cancer After Initial Chemotherapy

Study of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies